Effect of α-tocopherol on HDL oxidation

Pharmacology Reviews and Communications

Volumn 10, Issue 2, 1998, Pages 83-91

  Walters Laporte, Eveyne ^a   Boullier, Agnès ^a   Martin, Françoise ^a   Teissier, Elisabeth ^a   Decuypere, Laurent ^b   Taccoen, Alain ^b   Fruchart, Jean Charles ^a   Duriez, Patrick ^a  

^a INSERM   (France)

^b Immeuble Strasbourg   (France)

Author keywords

Conjugated diene; High density lipoprotein; Oxidation; tocopherol

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; ANTIOXIDANT; COPPER; HIGH DENSITY LIPOPROTEIN; OXIDIZING AGENT; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL;

EID: 0032411866     PISSN: 10288945     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Assman G, Shulbe H, Funke H, von Eckardstein A, Seedorf U (1989) in Miller NE (Ed), High density lipoprotein, Reverse cholesterol transport and coronary heart disease, Amsterdam, Exerpta Medica 46-59.
2. Bowry VW, Ingold KU, Stocker R (1992) (a) Vitamin E in human low density lipoprotein. When and how this antioxidant becomes a prooxidant. Biochem J 288, 341-344.
3. Bowry VW, Stanley KK, Stocker R (1992) (b) High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci USA 89, 10316-10320.
4. Bowry VW, Stocker R (1993) Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 115, 6029-6044.
5. Cominacini L, Carbin V, Cenci B, Davoli A, Pasini C, Ratti E, Gaviraghi G, LoCascio V, Pastorino AM (1991) Predis-position to LDL oxidation during copper-catalyzed oxidative modification and its relation to α-tocopherol content in human. Clin Chim Acta 204, 57-68.
6. De Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH (1991) Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscl and Thrornb 11, 298-306.
7. Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H (1991) Effect of oral supplementation with D-α-tocopherol on vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 32, 1325-1332.
8. Esterbauer H, Striegl G, Puhl H, Rotheneder M (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6, 67-75.
9. Gordon D. In/ Durrington PN (1992) Ed, HDL: Where should the clinician stand. Mark Allen Publishing, London, 17-20.
10. Havel RJ, Eder HS, Bradgon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 3, 1345-1353.
11. Hessler JR, Robertson AL, Ghislom GM (1979) LDL induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cell in culture. Atherosclerosis 32, 213-218.
12. Kleinveld HA, Naber AHJ, Stalenhoef AFH, Demacker PNM (1993) Oxidation resistance oxidation rate and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: Studies in vitamin E-deficient subjects. Free Radic Biol Med 15, 273-280.
13. Kontush A, Meyer S, Finckh B, Kohlschütter A, Beisiegel U (1996) α-Tocopherol as a reductant for Cu(II) in lipoproteins. Triggering role in the initiation of lipoprotein oxidation. J Biol Chem 271, 19, 11106-11112.
14. Mackness MI, Arrol S, Durington PN (1991) Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett, 286: 151-154.
15. Miller GJ, Miller NE (1975) Plasma high density lipoprotein concentration and the development of ischaemic heart disease. Lancet i: 6-8.
16. Nagano Y, Arai H, Kita T (1991) High density lipoprotein loses its effects to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci (USA) 88: 6457-6461.
17. Navab M, Imes SS, Hama SY (1991) Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 88, 2039-2045.
18. 2+ catalyzed oxidation of human low density lipoprotein. FEBS Lett 257, 435-438.
19. Parthasarathy S, Barnett J, Fong LG (1990) High density lipoprotein inhibits the oxidative modification of low density lipoprotein. Biochim Biophys Acta 1044, 275-278.
20. Peterson G (1977) A simplification of the protein assay method of Lowry which is more generally applicable 83, 346-356.
21. Rifici VA, Khachadurian AK (1996)-a Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages. Biochem Biophys Acta 1299: 87-94.
22. Rifici VA, Khachadurian AK (1996)-b Effects of dietary vitamin C and E supplementation on the copper mediated oxidation of HDL and on HDL mediated cholesterol efflux. Atherosclerosis 127: 19-26.
23. Rim EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willet WC (1993) Vitamin E consumption and the risk of coronary disease in men. N Engl J Med 328: 1450-1456.
24. Steinberg DS, Parthasarathy TE, Carrew JC, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modifications of low density lipoprotein that increase its athergenicity. N Engl J Med 320, 915-924.
25. Steinbrecher VP, Lougheed M, Kwan WC, Dirks M (1989) Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products fatty acid peroxidatton. J Biol Chem 264, 15216-15220.
26. Stocker R (1994) Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr Opin in Lipidol 5, 422-433.
27. Teissier E, Walters-Laporte E., Duhem C, Luc G, Fruchart JC, Duriez P (1995) A fast method of quantification of α-tocopherol in plasma and low and high density.lipoproteins. Clin Chem 42, 2: 430-435.
28. Witztum JL, Steinberg D (1991) Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88, 1785-1790.